Applied DNA Sciences Awarded Additional Funding from Stony Brook University

Jul 31, 2006, 01:00 ET from Applied DNA Sciences, Inc.

    STONY BROOK, N.Y., July 31 /PRNewswire-FirstCall/ -- Applied DNA
 Sciences, Inc. (OTC Bulletin Board:   APDN), a DNA security solutions
 company, today announced that its co-development project with Stony Brook
 University has been extended for at least a year based upon progress
 generated since the project began in February 2006. The initial grants
 funded the further development of APDN's DNA library and the completion of
 additional prototypes that will allow APDN to extend its platform to
 additional industries. APDN uses DNA encryption to authenticate products
 and identify counterfeits. Funding awarded to this project by the
 University's Center for Biotechnology ("Center"), a New York State Center
 for Advanced Technology, now totals $158,011.54.
     Dr. Clinton T. Rubin, Director, Center for Biotechnology and Professor
 and Chair, Department of Biomedical Engineering, Stony Brook University,
 stated, "We are very pleased to continue to facilitate the collaboration
 between the Center and Applied DNA Sciences. This grant will help continue
 to provide resources and support to fuel the growth and commercialization
 of forensic- based technologies."
     Leading this project on behalf of the Center is Dr. Sanford Simon,
 Professor of Biochemistry, Cell Biology, and Pathology, Stony Brook
 University, and a director of APDN, "The first stage of this project, which
 is essentially creating a library of unique sequences of plant DNA, has
 been completed."
     "Thanks to the support from the Center for Biotechnology for this
 project, we are able to extend our uses of the company's unique plant
 chimers into new commercial markets that have been heretofore inaccessible
 for DNA markings. We are now expanding our reach from consumer products and
 art to pharmaceuticals. The first grant has helped APDN to assemble
 prototypes of products that we can demonstrate to our clients," stated Dr.
 Benjamin Liang, Strategic Technology Officer for Applied DNA Sciences.
     About Applied DNA Sciences, Inc.
     Applied DNA Sciences, Inc. (APDN) develops proprietary DNA-embedded
 security solutions that use plant DNA to verify authenticity and protect
 corporate and government agencies from counterfeiting, fraud, piracy,
 product diversion, identity theft and unauthorized intrusion into physical
 plant and databases. Our common stock is registered under Section 12(g) of
 the Securities Exchange Act of 1934 and is listed on the Over-The-Counter
 Bulletin Board under the symbol "APDN". Contact: MeiLin Wan, Applied DNA
 Sciences, Inc., 25 Health Sciences Drive, Stony Brook, New York 11790; Tel:
 631-444- 6370; Fax: 631-444.8848
     The statements made by Applied DNA Sciences, Inc. may be
 forward-looking in nature and are made pursuant to the safe harbor
 provisions of the Private Securities Litigation Reform Act of 1995.
 Forward-looking statements describe the Company's future plans,
 projections, strategies and expectations, and are based on assumptions and
 involve a number of risks and uncertainties, many of which are beyond the
 control of Applied DNA Sciences, Inc. Actual results could differ
 materially from those projected due to changes in interest rates, market
 competition, changes in the local and national economies, and various other
 factors detailed from time to time in Applied DNA Sciences' SEC reports and
 filings, including our Annual Report on Form 10-KSB, filed on January 12,
 2006, our subsequent Quarterly Reports on Form 10-QSB, and our Current
 Reports on Form 8-K. The Company undertakes no obligation to update
 publicly any forward-looking statements to reflect new information, events
 or circumstances after the date hereof to reflect the occurrence of
 unanticipated events.

SOURCE Applied DNA Sciences, Inc.